Antiatherogenic effects of the antioxidant BO-653 in three different animal models.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1998-08-18

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1073/PNAS.95.17.10123PMID 9707611PMCID PMC21472
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 2,3-Dihydro-5-hydroxy-2,2-dipentyl-4,6-di-tert-butylbenzofuran: design and evaluation as a novel radical-scavenging antioxidant against lipid peroxidation.

  1997cited by this paper
• A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection

  1997cited by this paper
• Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice.

  1997cited by this paper
• Prevention of atherosclerosis with dietary antioxidants: fact or fiction?

  1996cited by this paper
• Clinical trials of antioxidants in atherosclerosis: are we doing the right thing?

  1995cited by this paper
• Probucol treatment decreases serum concentrations of diet-derived antioxidants.

  1995cited by this paper
• Lowering of HDL2b by probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia. A Probucol Quantitative Regression Swedish Trial (PQRST) Report.

  1995cited by this paper
• Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption.

  1994cited by this paper
• Characterization of aggregated low density lipoproteins induced by copper-catalyzed oxidation.

  1994cited by this paper
• The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST).

  1994cited by this paper
• The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers.

  1994cited by this paper
• Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population.

  1993cited by this paper
• Atherosclerosis and plasma and liver lipids in nine inbred strains of mice

  1993cited by this paper
• Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.

  1993cited by this paper
• Vitamin E consumption and the risk of coronary heart disease in men.

  1993cited by this paper
• Antioxidant activities of probucol against lipid peroxidations.

  1992cited by this paper
• Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits.

  1992cited by this paper
• Role of oxidized low density lipoprotein in atherogenesis.

  1991cited by this paper
• Therapeutic potential of vitamin E in the pathogenesis of spontaneous atherosclerosis.

  1991cited by this paper
• Antioxidant activity of probucol and its effects on phase transitions in phosphatidylcholine liposomes.

  1990cited by this paper
• Determination of superoxide radical and singlet oxygen based on chemiluminescence of luciferin analogs.

  1990cited by this paper
• Synthetic low and high fat diets for the study of atherosclerosis in the mouse.

  1990cited by this paper
• Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

  1989cited by this paper
• Potentiation of atherosclerotic lesions in rabbits by a high dietary level of vitamin E

  1989cited by this paper
• Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.

  1987cited by this paper
• Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis.

  1987cited by this paper
• A new vitamin E analogue more active than α‐tocopherol in the rat curative myopathy bioassay

  1986cited by this paper
• A new vitamin E analogue more active than alpha-tocopherol in the rat curative myopathy bioassay.

  1986cited by this paper
• Estimation of the location of natural α-tocopherol in lipid bilayers by 13C-NMR spectroscopy☆

  1985cited by this paper
• Estimation of the location of natural alpha-tocopherol in lipid bilayers by 13C-NMR spectroscopy.

  1985cited by this paper
• Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis.

  1983cited by this paper
• Impaired receptor-mediated catabolism of low density lipoprotein in the WHHL rabbit, an animal model of familial hypercholesterolemia.

  1982cited by this paper
• Cancer prevention Study II.

  1982cited by this paper
• Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins A1 and A2 in adults with primary familial hypercholesterolemia.

  1980cited by this paper
• Macrophages.

  1979cited by this paper
• The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations.

  1972cited by this paper

• The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases

  2024cites this paper
• Effect of a new squalene synthase inhibitor on an ApoE-/- mouse model of atherosclerosis.

  2023cites this paper
• Antioxidants in the Fight Against Atherosclerosis: Is This a Dead End?

  2018cites this paper
• Balancing Antioxidant, Hypolipidemic and Anti-inflammatory Activity in a Single Agent: The Example of 2-Hydroxy-2-Substituted Morpholine, 1,4-Benzoxazine and 1,4-Benzothiazine Derivatives as a Rational Therapeutic Approach against Atherosclerosis.

  2017cites this paper
• Antioxidants in Translational Medicine

  2015cites this paper
• A Mathematical Model of Atherosclerosis with Reverse Cholesterol Transport and Associated Risk Factors

  2014cites this paper
• Multi-target drug design approaches for multifactorial diseases: from neurodegenerative to cardiovascular applications.

  2014cites this paper
• Molecular function of tocopherols in age related diseases.

  2014cites this paper
• Synthetic lipophilic antioxidant BO‐653 suppresses HCV replication

  2013cites this paper
• Avaliação da atividade antioxidante de diferentes classes decompostos contra a oxidação de lipoproteínas de baixa densidade

  2011cites this paper
• Comparison of anti-atherosclerotic effects of two different extracts from leaves of Mallotus furetianus.

  2011cites this paper
• Antioxidant Nanoparticles as Delivery Systems

  2010cites this paper
• Design, synthesis, and action of antiatherogenic antioxidants.

  2010cites this paper
• Novel Synthetic Antioxidants and Nitrated Lipids: From Physiology to Therapeutic Implications

  2010cites this paper
• Do free radicals play causal role in atherosclerosis? Low density lipoprotein oxidation and vitamin E revisited

  2010cites this paper
• Assessment of antioxidant capacity of natural products.

  2010cites this paper
• Escherichia coli lipopolysaccharide administration alters antioxidant profile during hypercholesterolemia

  2009cites this paper
• In search of antioxidants and anti‐atherosclerotic agents from herbal medicines

  2008cites this paper
• Oximes as inhibitors of low density lipoprotein oxidation.

  2008cites this paper
• Antitumor and antioxidant activity of protocatechualdehyde produced from Streptomyces lincolnensis M-20

  2008cites this paper
• コレステロール負荷家兎における後醗酵茶「碁石茶」の高脂血症及び動脈硬化抑制効果

  2008cites this paper
• [Inhibitory effects of "Goishi-tea" as a post-fermented-tea on dietary-induced hypercholesteremia and atherosclerosis in rabbits].

  2008cites this paper
• Antioxidants derived from vitamin E: an overview.

  2007cites this paper
• Effect of Kokuto, a non-centrifugal cane sugar, on the development of experimental atherosclerosis in Japanese quail and apolipoprotein E deficient mice

  2007cites this paper
• Inhibitors of the Expression of Vascular Cell Adhesion Molecule-1

  2006cites this paper
• The antiatherogenic effect of DiNAC: experimental findings supporting immunomodulation as a new treatment for atherosclerosis related diseases.

  2006cites this paper
• Antioxidants and Chronic Vascular Disease: Animal Studies

  2006cites this paper
• Protective effect of vitamin E supplements on experimental atherosclerosis is modest and depends on preexisting vitamin E deficiency.

  2006cites this paper
• Atherosclerosis is an inflammatory disorder after all.

  2006cites this paper
• Inflammation in atherosclerosis: new opportunities for drug discovery.

  2005cites this paper
• Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis.

  2005cites this paper
• Characterization of the oxidation products of BO-653 formed during peroxyl radical-mediated oxidation of human plasma.

  2005cites this paper
• New trends in anti-atherosclerotic agents.

  2005cites this paper
• Lipid-soluble 3-pyridinol antioxidants spare alpha-tocopherol and do not efficiently mediate peroxidation of cholesterol esters in human low-density lipoprotein.

  2005cites this paper
• Inhibition of lipoprotein lipid oxidation.

  2005cites this paper
• Pharmacological basis of different targets for the treatment of atherosclerosis

  2005cites this paper
• Lysophosphatidylcholine Enhances Cytokine Production of Endothelial Cells via Induction of L-Type Amino Acid Transporter 1 and Cell Surface Antigen 4F2

  2004cites this paper
• Novel (3,5-di-tert-butyl-2-hydroxy-phenylcarbamoyl)-alkanoic acids as potent antioxidants.

  2004cites this paper
• The role of ROS and RNS in regulating life and death of blood monocytes.

  2004cites this paper
• Role of oxidative modifications in atherosclerosis.

  2004cites this paper
• Effects of antioxidants against atherosclerosis

  2004cites this paper
• Antioxidants and atherosclerosis.

  2004cites this paper
• Evaluation of a soft atherosclerotic lesion in the rabbit aorta by an invasive IVUS method versus a non-invasive MRI technology.

  2004cites this paper
• Inhibition of plasma lipid peroxidation by anti-atherogenic antioxidant BO-653, 2,3-dihydro-5-hydroxy-4,6-di-tert-butyl-2,2-dipentylbenzofuran.

  2004cites this paper
• Antioxidants: New-generation therapeutic base for treatment of polygenic disorders

  2004cites this paper
• Histidine adducts of 4HNE were measured by using a competitive ELISA for HNE-adducts according to the literature with a slight modification

  2004cites this paper
• Inhibitory effects of Hibiscus sabdariffa L extract on low-density lipoprotein oxidation and anti-hyperlipidemia in fructose-fed and cholesterol-fed rats

  2004cites this paper
• Oxidized Low-density Lipoprotein Inhibits Endothelium-dependent Vasodilation by an Antioxidant-sensitive, Lysophosphatidylcholine-independent Mechanism

  2003cites this paper
• The role of alpha-tocopherol in preventing disease: from epidemiology to molecular events.

  2003cites this paper
• The role of α-tocopherol in preventing disease: from epidemiology to molecular events

  2003cites this paper
• Use of NEP-associated molecules for the treatment of diseases of civilization nonimmunogenic-nichthypertensiven

  2003cites this paper
• Coenzyme Q(10) supplementation inhibits aortic lipid oxidation but fails to attenuate intimal thickening in balloon-injured New Zealand white rabbits.

  2003cites this paper
• Coenzyme Q10 supplementation inhibits aortic lipid oxidation but fails to attenuate intimal thickening in balloon-injured New Zealand white rabbits

  2003cites this paper
• Design and synthesis of 4,6-di-tert-butyl-2,3-dihydro-5-benzofuranols as a novel series of antiatherogenic antioxidants.

  2003cites this paper
• Composition destinee a prevenir l'arteriosclerose

  2003cites this paper
• Vitamin E Reduces Progression of Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice With Established Vascular Lesions

  2003cites this paper
• Effects of antioxidants against atherosclerosis.

  2002cites this paper
• Lipoprotein metabolism and molecular pathogenesis of atherosclerosis

  2002cites this paper
• Effect of BO-653 and probucol on c-MYC and PDGF-A messenger RNA of the iliac artery after balloon denudation in cholesterol-fed rabbits.

  2002cites this paper
• Antioxidant Action of 2,2,4,6-Tetra-Substituted 2,3-Dihydro-5-hydroxybenzofuran Against Lipid Peroxidation: Effects of Substituents and Side Chain

  2002cites this paper
• Inhibitory effect of a novel water-soluble vitamin E derivative on atherosclerosis in rabbits.

  2002cites this paper
• Novel insights into the molecular mechanisms of the antiatherosclerotic properties of antioxidants: the alternatives to radical scavenging.

  2002cites this paper
• Vascular oxidative stress and antioxidant protection in atherosclerosis: what do the clinical trials say?

  2002cites this paper
• Antioxidants and atherosclerosis

  2002cites this paper
• Anti-atherogenic Antioxidants Regulate the Expression and Function of Proteasome α-Type Subunits in Human Endothelial Cells*

  2001cites this paper
• Effect of Probucol in Lecithin-Cholesterol Acyltransferase–Deficient Mice: Inhibition of 2 Independent Cellular Cholesterol–Releasing Pathways In Vivo

  2001cites this paper
• Lipid Peroxidation and Its Inhibition : Overview and Perspectives

  2001cites this paper
• Lipid peroxidation in mouse models of atherosclerosis.

  2001cites this paper
• Lipid Peroxidation and Platelet Activation in Murine Atherosclerosis

  2001cites this paper
• [Scavenger receptors and pathogenesis of atherosclerosis].

  2001cites this paper
• Dietary Cosupplementation With Vitamin E and Coenzyme Q10 Inhibits Atherosclerosis in Apolipoprotein E Gene Knockout Mice

  2001cites this paper
• α-Tocopherol Transfer Protein Is Important for the Normal Development of Placental Labyrinthine Trophoblasts in Mice*

  2001cites this paper
• Gene Transfer of Extracellular Superoxide Dismutase to Atherosclerotic Mice

  2001cites this paper
• Mouse Models of Atherosclerosis

  2001cites this paper
• The oxidative modification hypothesis of atherosclerosis: does it hold for humans?

  2001cites this paper
• Macrophage scavenger receptor (SR-A I/II) deficiency reduced diet-induced atherosclerosis in C57BL/6J mice.

  2001cites this paper
• Antioxidant therapy and atherosclerosis: animal and human studies.

  2001cites this paper
• Antioxidants and Atherosclerosis: Animal Studies

  2000cites this paper
• Molecular action of vitamin E in lipoprotein oxidation: implications for atherosclerosis.

  2000cites this paper
• Taurine reduces atherosclerotic lesion development in apolipoprotein E-deficient mice.

  2000cites this paper
• Is there a potential therapeutic role for vitamin E or other antioxidants in atherosclerosis?

  2000cites this paper
• Antioxidants and Cardiovascular Disease

  2000cites this paper
• Phenolic antioxidants: a rationale for design and evaluation of novel antioxidant drug for atherosclerosis.

  2000cites this paper
• Anti-atherogenic effect of coenzyme Q10 in apolipoprotein E gene knockout mice.

  2000cites this paper
• Cell signaling by reactive nitrogen and oxygen species in atherosclerosis.

  2000cites this paper
• Apolipoprotein-mediated cellular cholesterol/phospholipid efflux and plasma high density lipoprotein level in mice.

  2000cites this paper
• Evaluation of Antioxidant Capacity. What Capacity is being Measured by Which Method?

  2000cites this paper
• Vitamin E: non-antioxidant roles.

  2000cites this paper
• Gene expression induced by BO-653, probucol and BHQ in human endothelial cells.

  2000cites this paper
• Antioxidants and vascular disease: animal studies.

  2000cites this paper
• Site-specific antiatherogenic effect of probucol in apolipoprotein E-deficient mice

  2000cites this paper
• The Oxidative Modification Hypothesis of Atherogenesis

  2000cites this paper
• The oxidative modification hypothesis of atherogenesis: an overview.

  2000cites this paper
• Atherosclerosis: from lesion formation to plaque activation and endothelial dysfunction.

  2000cites this paper
• Dietary Phenols: Antioxidants for the Brain?

  2000cites this paper
• Diverse functions of antioxidants

  2000cites this paper
• Effects of antioxidants on vascular health.

  1999cites this paper
• Role of oxidatively modified low density lipoproteins and anti-oxidants in atherothrombosis.

  1999cites this paper
• A role for reduced coenzyme Q in atherosclerosis?

  1999cites this paper
• The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties.

  1999cites this paper